ArticleNature communications2026
A glycolytic intermediate gatekeeps global mRNA decay in Escherichia coli.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Polynucleotide phosphorylase (PNPase) is a highly conserved exoribonuclease crucial for RNA degradation across all domains of life. In bacteria, PNPase is found in multi-protein ribonucleolytic complexes that include glycolytic enzymes. While evidence supports a link between RNA degradation and glycolysis in Escherichia coli, the precise contribution of PNPase and the underlying regulatory mechanism remain unknown. Here we establish PNPase as a metabolic sensor that physically and functionally links glycolysis to RNA stability. We find that the intermediate of glycolysis, fructose 1,6-diphosphate, binds to and inhibits E. coli PNPase activity in vitro. This inhibition is confirmed in vivo, where increasing the levels of this metabolite compromises growth and globally prolongs RNA half-lives in an E. coli strain where PNPase is essential for growth. Bacterial two-hybrid and in vivo crosslinking followed by immunoprecipitation suggest potential interaction between PNPase and multiple glycolytic enzymes. Our results propose a mechanism where RNA phosphorolysis by PNPase, an energy-saving RNA degradation pathway, is directly modulated by a glycolytic metabolite and facilitated by metabolon association. This mechanism links the metabolic state of the cell to post-transcriptional control of gene expression. This regulatory system is likely exploited by other bacterial species relevant to human health, environment and industry, particularly those that rely on PNPase as the sole exoribonuclease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.